SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank65
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P65
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-5.80%
Q3 2025508.87%
Q2 2025-20.96%
Q1 2025-13.75%
Q4 2024-17.85%
Q3 2024-13.08%
Q2 2024-13.28%
Q1 2024-14.97%
Q4 2023196.23%
Q3 2023-20.05%
Q2 2023-16.94%
Q1 2023-16.17%
Q4 2022-3.05%
Q3 2022-11.24%
Q2 2022-12.33%
Q1 2022-16.85%
Q4 202158.69%
Q3 2021-5.68%
Q2 2021-53.77%
Q1 2021107.42%
Q4 20200.00%